Narcolepsy Therapeutics Market PPT
                                 
                       
 
                   
 
                Narcolepsy Therapeutics Market 
 
  
 
 
• Narcolepsy Therapeutics Market Size Worth USD 7,852.93 Million by 2034 | 
CAGR: 7.5%
“Narcolepsy Therapeutics Market Size, Share, Trends, Industry Analysis Report: 
By Treatment (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and 
Secondary Narcolepsy), Product, and Region (North America, Europe, Asia Pacific, 
Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” 

                        
    
                 Narcolepsy Therapeutics Market  
  
 
• The narcolepsy therapeutics market size was valued at USD 3,819.10 million in 
2024. The market is projected to grow from USD 4,095.99 million in 2025 to 
USD 7,852.93 million by 2034, exhibiting a CAGR of 7.5% during 2025–2034.
Request To Sample :
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-thera
peutics-market/request-for-sample
•.
             Narcolepsy Therapeutics Market  
• List of Key Companies in Narcolepsy Therapeutics Market
• Addrenex Pharmaceuticals, Inc.
• Arena Pharmaceuticals, Inc.
• Avadel Pharmaceuticals plc
• Axsome Therapeutics, Inc.
• BIOPROJET
• Graymark Healthcare, Inc.
• Harmony Biosciences Holdings, Inc.
• Janssen Global Services, LLC
           Narcolepsy Therapeutics Market  
  
•Narcolepsy Therapeutics Market Report Highlights
• Based on treatment, the narcolepsy with cataplexy segment dominated the narcolepsy therapeutics market share in 
2024 due to the high prevalence of cataplexy among narcolepsy patients and the availability of effective treatments 
such as sodium oxybate. However, the narcolepsy without cataplexy segment is growing steadily as treatments for 
excessive daytime sleepiness gain traction.
• In terms of product, the sodium oxybate segment dominated the narcolepsy therapeutics market revenue in 2024, 
owing to its proven efficacy in treating both cataplexy and excessive daytime sleepiness in narcolepsy patients. The 
central nervous system stimulants segment is showing strong growth as a primary treatment for managing sleepiness.
• North America held the major market share in 2024 due to advanced healthcare infrastructure and high awareness 
levels. However, Asia Pacific is the fastest-growing region, fueled by improving healthcare access and rising awareness 
of narcolepsy.
Buy Now :
https://www.polarismarketresearch.com/buy/263/0
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give 
unmatched nature of offering to our customers present all around the globe across industry 
verticals. Polaris Market Research has expertise in giving deep-dive market insight along with 
market intelligence to our customers spread crosswise over various undertakings. We at Polaris 
are obliged to serve our different client base present over the enterprises of medicinal services, 
healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and 
aerospace & defense, among different ventures present globally.
𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗜𝗻𝗳𝗼:
Polaris Market Research
Phone: +1-929-297-9727
Email: [email protected]